Low-dose 500 mg abiraterone acetate achieved effective suppression of androgen synthesis in prostate cancer patients in a Phase 1 proof-ofconcept clinical study
BJU INTERNATIONAL(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BJU INTERNATIONAL(2023)